Both in Pharmaceuticals
Clene vs RenovoRx
Over the past year CLNN returned −62.5% and RNXT returned +28.4%; their daily moves had a correlation of 0.08.
CLNN −62.5% RNXT +28.4%Growth of $1, one year, split-adjusted
| Metric | CLNN | RNXT |
|---|---|---|
| Price | $4.10 | $1.31 |
| Market cap | $58.3M | $59.1M |
| Today | +8.75% | +1.55% |
| 1 month | +5.9% | −5.8% |
| 6 months | −42.7% | +47.2% |
| Year to date | −30.2% | +55.9% |
| 1 year | −65.8% | +20.2% |
| Revenue growth (YoY) | +233.3% | +115.4% |
| Gross margin | 60.0% | 84.3% |
| Net margin | −14915.6% | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | 295.8× | 29.9× |
| Net cash | -$9.1M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 108.4% |
| Short % of float | 4.6% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).